Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q55456962)
Watch
English
Biological Role and Therapeutic Potential of IDH Mutations in Cancer.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
title
Biological Role and Therapeutic Potential of IDH Mutations in Cancer
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
author
Bill H Diplas
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
author name string
Matthew S Waitkus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Hai Yan
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
publication date
24 May 2018
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
published in
Cancer Cell
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
volume
34
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
page(s)
186-195
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
cites work
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Enasidenib: First Global Approval.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Correlation of immune phenotype with IDH mutation in diffuse glioma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Mutant IDH1 regulates the tumor-associated immune system in gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase mutations in myeloid malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Integrated genomic characterization of IDH1-mutant glioma malignant progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase mutations in gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
A vaccine targeting mutant IDH1 induces antitumour immunity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
TET enzymes, TDG and the dynamics of DNA demethylation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Targeting MYCN in neuroblastoma by BET bromodomain inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH mutation impairs histone demethylation and results in a block to cell differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
An in vivo patient-derived model of endogenous IDH1-mutant glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Glioma IDH1 mutation patterns off the beaten track.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Recurring mutations found by sequencing an acute myeloid leukemia genome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
IDH1 and IDH2 mutations in gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
An integrated genomic analysis of human glioblastoma multiforme
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
The genomic landscapes of human breast and colorectal cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6092238
retrieved
7 September 2018
Multiple NADPH-producing pathways control glutathione (GSH) content in retina
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/29805076
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.CCELL.2018.04.011
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
PMC publication ID
6092238
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
PubMed publication ID
29805076
1 reference
stated in
Europe PubMed Central
PMC publication ID
6092238
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29805076%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit